Assignee
SPOTLIGHT THERAPEUTICS
US·0 granted patents·6 pending applications·0 citations·filing 2021–2024
Top patents by PatentIndex Score
6 records- 0169US2024209355A1Nucleic acid binding protein formulations and uses thereofSPOTLIGHT THERAPEUTICS·Filed 2023·Application pending·0 cites
- 0255US2022002695A1Targeted active gene editing agent and methods of useSPOTLIGHT THERAPEUTICS·Filed 2021·Application pending·0 cites
- 0354US2022010337A1Targeted active gene editing agent and methods of useSPOTLIGHT THERAPEUTICS·Filed 2021·Application pending·0 cites
- 0452US2024409923A1Guide rnas and uses thereofSPOTLIGHT THERAPEUTICS·Filed 2024·Application pending·0 cites
- 0551US2024327819A1Adar specific guide rnas and uses thereofSPOTLIGHT THERAPEUTICS·Filed 2023·Application pending·0 cites
- 0639US2022033808A1Methods and compositions for nucleic acid-guided nuclease cell targeting screenSPOTLIGHT THERAPEUTICS·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SPOTLIGHT THERAPEUTICS files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →